THE LITERATURE / NOV 16 2026
GHK-Cu vs AHK-Cu, and What's in GLOW vs KLOW
GHK and AHK differ by one amino acid. The indexed laboratory record for GHK-Cu is much larger than the record for AHK-Cu. GLOW and KLOW are catalogue blends, and the pages say what each vial contains.

Two similar names are doing different jobs in this literature. GHK-Cu and AHK-Cu are copper complexes of tripeptides that differ by one residue. GLOW and KLOW are names on this catalogue for mixtures that include GHK-Cu. The mixtures are not the peptides the papers named, and the papers are not a description of the vials.
One amino acid
GHK is glycyl-L-histidyl-L-lysine. Schlesinger, Pickart and Thaler gave that identification in 1977, and Bossak-Ahmad and colleagues write it as Gly–His–Lys. AHK-Cu, in the 2007 paper by Pyo and colleagues, is L-alanyl-L-histidyl-L-lysine copper(II).
Read the names from the left. Glycyl against alanyl: the first residue is glycine in GHK and alanine in AHK. Histidyl and lysyl are the same in both names. That is one amino acid. The copper(II) complex of GHK, and the spectroscopy that places its visible band near 606 to 610 nm, are described in Why Is GHK-Cu Blue?.
What the indexed record contains
A count is not a review. It does show the size of the record an index will return under a stated query. On 16 November 2026, NCBI's PubMed index returned these counts:
| Query, limited to title or abstract | Records |
|---|---|
| "GHK-Cu" | 85 |
| "glycyl-L-histidyl-L-lysine" OR "glycyl-histidyl-lysine" OR "GHK-Cu" | 164 |
| "AHK-Cu" | 1 |
| "L-alanyl-L-histidyl-L-lysine" | 1 |
The single AHK-Cu record, and the single L-alanyl-L-histidyl-L-lysine record, are the same paper: Pyo and colleagues, 2007. The GHK queries return a larger set. Searches miss papers that use other wording, and they pick up papers that use the string without being a study of the complex. They are not a systematic review, and the numbers will move when the index does.
The GHK dates that can be checked from the papers themselves run for decades, and they include both cell-culture work and an animal experiment:
- Pickart and Thaler, 1973, Nature New Biology, reported a tripeptide from human serum in a liver-cell culture experiment. The 1977 paper is the identification of that tripeptide as glycyl-histidyl-lysine.
- Pickart, Freedman and colleagues, 1980, Nature, reported that the tripeptide forms complexes with copper(II). The paper used cultured cells. This article does not restate the rest of their report.
- Lau and Sarkar, 1981, Biochemical Journal, and Freedman and colleagues, 1982, Biochemistry, are solution studies of the copper(II) complex.
- Maquart and colleagues, 1993, Journal of Clinical Investigation, published an experiment in rats. This article does not restate what they measured.
- Bossak-Ahmad and colleagues, 2020, and Ufnalska and colleagues, 2021, are later solution-chemistry papers on Cu(II)GHK.
That is the sense in which GHK-Cu has a long in vitro record and at least one published animal experiment. "In vitro" here means the cell-culture and solution work. The 1993 paper is the animal experiment in this list. None of those sentences is a finding carried over from the papers. The titles and the experimental systems are what is being cited.
The 2007 AHK-Cu paper
Pyo and colleagues published "The effect of tripeptide-copper complex on human hair growth in vitro" in Archives of Pharmacal Research in 2007. The abstract names the complex as L-alanyl-L-histidyl-L-lysine-Cu2+ and says the experiments used cultured dermal papilla cells and human hair follicles kept ex vivo. It is an in vitro and ex vivo paper. This article does not restate the authors' conclusions, and it does not turn one paper into a body of work.
A search that returns one paper is not proof that no other paper exists. It is what those queries returned on that date. Under the queries above, the AHK-Cu record is far smaller than the GHK-Cu record.
What GLOW and KLOW contain
GLOW and KLOW are catalogue names. They are not names in the papers above.
The Glow Blend page lists three constituents in one lyophilized vial: GHK-Cu, BPC-157 and TB-500. The labeled fill printed there is 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500. Those figures are the labeled contents of that research vial.
The KLOW Blend page names four constituents in one lyophilized vial: KPV, GHK-Cu, TB-500 and BPC-157. The page does not publish how the fill is divided among the four. This article does not estimate a split, and a split inferred from the total on the label would be a guess.
The PubMed queries above were for the tripeptide names, not for these blends. A vial that contains several peptides is a mixture of the named materials. It is not a new sequence. None of the papers in the source list is a study of these two catalogue products.
Frequently asked questions
How is AHK-Cu different from GHK-Cu?
The sequences differ by one residue. GHK is glycyl-L-histidyl-L-lysine. A 2007 paper names AHK-Cu as L-alanyl-L-histidyl-L-lysine copper(II). The first residue is glycine in GHK and alanine in AHK. Histidine and lysine are the same in both names.
How much published research is there for each?
On 16 November 2026, a PubMed search for GHK-Cu in the title or abstract returned 85 records. The same kind of search for AHK-Cu returned one record, a 2007 paper. A wider search for the GHK names returned 164 records. Those are index counts, not a systematic review.
What did the 2007 AHK-Cu paper study?
Pyo and colleagues studied L-alanyl-L-histidyl-L-lysine copper(II) in cultured dermal papilla cells and in human hair follicles kept ex vivo. This article does not restate their conclusions.
What is in the GLOW blend?
The Glow Blend page lists GHK-Cu, BPC-157 and TB-500 in one vial. The labeled fill on that page is 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500. Those figures are the labeled contents of the research vial.
What is in the KLOW blend?
The KLOW Blend page names KPV, GHK-Cu, TB-500 and BPC-157 in one vial. It does not publish how the fill is divided among the four constituents. This article does not estimate a split.
Questions on a specific compound? The research desk answers with documentation. Contact the research desk or browse the research library.
Sources
- Schlesinger DH, Pickart L, Thaler MM. "Growth-modulating serum tripeptide is glycyl-histidyl-lysine." Experientia. 1977;33(3):324–325. PMID 858356. https://pubmed.ncbi.nlm.nih.gov/858356/
- Bossak-Ahmad K, Wiśniewska MD, Bal W, Drew SC, Frączyk T. "Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate." International Journal of Molecular Sciences. 2020;21(17):6190. PMID 32867146. https://pmc.ncbi.nlm.nih.gov/articles/PMC7503498/
- Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. "The effect of tripeptide-copper complex on human hair growth in vitro." Archives of Pharmacal Research. 2007;30(7):834–839. PMID 17703734. https://pubmed.ncbi.nlm.nih.gov/17703734/
- PubMed search, 16 November 2026, title/abstract: "GHK-Cu" (85 records); "AHK-Cu" (1 record, PMID 17703734); "L-alanyl-L-histidyl-L-lysine" (1 record, PMID 17703734); "glycyl-L-histidyl-L-lysine" OR "glycyl-histidyl-lysine" OR "GHK-Cu" (164 records). https://pubmed.ncbi.nlm.nih.gov/
- Pickart L, Thaler MM. "Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver." Nature New Biology. 1973;243(124):85–87. PMID 4349963. https://pubmed.ncbi.nlm.nih.gov/4349963/
- Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE, Weinstein B. "Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells." Nature. 1980;288(5792):715–717. PMID 7453802. https://doi.org/10.1038/288715a0
- Lau SJ, Sarkar B. "The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a growth-modulating tripeptide from plasma." Biochemical Journal. 1981;199(3):649–656. PMID 7340824. https://doi.org/10.1042/bj1990649
- Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J. "Structure of the glycyl-L-histidyl-L-lysine–copper(II) complex in solution." Biochemistry. 1982;21(19):4540–4544. PMID 6291585. https://doi.org/10.1021/bi00262a004
- Maquart FX, Bellon G, Chaqour B, Wegrowski J, Patt LM, Trachy RE, Monboisse JC, Chastang F, Birembaut P, Gillery P. "In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds." Journal of Clinical Investigation. 1993;92(5):2368–2376. PMID 8227353. https://pubmed.ncbi.nlm.nih.gov/8227353/
- Ufnalska I, Drew SC, Zhukov I, Szutkowski K, Wawrzyniak UE, Wróblewski W, Frączyk T, Bal W. "Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione." Inorganic Chemistry. 2021;60(23):18048–18057. PMID 34781677. https://pmc.ncbi.nlm.nih.gov/articles/PMC8653159/
- Klean Research catalogue. Glow Blend. https://www.kleanresearch.com/products/glow
- Klean Research catalogue. KLOW Blend. https://www.kleanresearch.com/products/klow
- Klean Research catalogue. GHK-Cu. https://www.kleanresearch.com/products/ghk-cu
KLEAN. — RESEARCH DESK
Questions on a specific compound? The research desk answers with documentation.
CONTINUE READING
